Clifford Chance Guides Cinven's $589M Pharma Co. Buy
Private equity-backed Cinven Partners LLP has acquired international drug manufacturer Amdipharm Group from its private owners for about £367 million ($589.5 million), in its second major move this year in the...To view the full article, register now.
Already a subscriber? Click here to view full article